Coronavirus disease 2019 (COVID-19) is an infectious viral disease caused by Severe
Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). It is known that infection with …

Glucocorticoids, but not other DMARDs, are associated with a higher risk of severe COVID-
19 outcomes in RA patients. Further studies are needed to explore the impact of specific …

Patients with immune-mediated inflammatory diseases (IMIDs), such as rheumatoid arthritis
and inflammatory bowel disease, are at increased risk of infection. International guidelines …

Objective Patients with rheumatoid arthritis (RA) are at an increased risk of acquiring
infections owing to immunologic dysfunction and use of potent immunomodulatory …

Background The COVID-19 pandemic has raised numerous questions among patients with
immune-mediated inflammatory diseases regarding potential reciprocal effects of COVID-19 …

Introduction In Hungary, the HUN-VE 3 study determined the comparative effectiveness of
various primary and booster vaccination strategies during the Delta COVID-19 wave. That …

Background The impact and consequences of the COVID-19 pandemic on people with
rheumatic disease are unclear. We developed the COVID-19 Global Rheumatology Alliance …

Background The novel coronavirus (COVID-19), caused by SARS-CoV-2, showed various
prevalence and case-fatality rates (CFR) among patients with different pre-existing chronic …

Systemic autoimmune diseases (SAD) are a heterogeneous group of diseases with a
common aetiopathogenic basis affecting all ages characterised by a systemic phenotypic …

The Coronavirus disease 2019 (COVID-19) pandemic has represented an unprecedented
challenge for humankind from health, economic, and social viewpoints. In February 2020 …